Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Pharmaron Beijing Total Liabilities (Quarterly): 1.420B for March 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | 1.420B |
| December 31, 2022 | 1.399B |
| September 30, 2022 | 1.286B |
| June 30, 2022 | 1.295B |
| June 30, 2022 | 1.295B |
| March 31, 2022 | 1.308B |
| December 31, 2021 | 1.270B |
| September 30, 2021 | 1.179B |
| June 30, 2021 | 1.165B |
| June 30, 2021 | 1.165B |
| March 31, 2021 | 548.44M |
| December 31, 2020 | 455.37M |
| September 30, 2020 | 286.60M |
| Date | Value |
|---|---|
| June 30, 2020 | 250.30M |
| June 30, 2020 | 250.30M |
| March 31, 2020 | 190.71M |
| December 31, 2019 | 299.71M |
| September 30, 2019 | 351.39M |
| June 30, 2019 | 352.99M |
| June 30, 2019 | 352.99M |
| March 31, 2019 | 344.15M |
| December 31, 2018 | 359.86M |
| September 30, 2018 | 325.32M |
| June 30, 2018 | 322.64M |
| June 30, 2018 | 322.64M |
| December 31, 2017 | 292.38M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
190.71M
Minimum
Mar 2020
1.420B
Maximum
Mar 2023
886.15M
Average
1.165B
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Sino Biopharmaceutical Ltd | 3.382B |
| HUTCHMED (China) Ltd | 508.85M |
| Regencell Bioscience Holdings Ltd | 0.2195M |
| Prenetics Global Ltd | 42.30M |
| Uni-Bio Science Group Ltd | 22.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.058B |
| Shareholders Equity (Quarterly) | 1.595B |